He certainly left New Merck CEO Ken Frazier holding another Hassan bag of smoldering dung, this morning, no?
Okay -- less pungently -- today's New Merck write-off, of another $1.7 billion of Ex-Schering-Plough CEO "Fast" Fred Hassan's hype leads to an obvious question:
. . . .How is it that Whitehouse Station got snowed by this guy (with Carrie S. Cox, Bob Bertolini, and Tom Sabatino and Tom Koestler helping, here -- as well)?
For Hassan and Cox, this is now the third time they'd done this -- first as they exited AHP, then as they sold Pharmacia to Pfizer. . . and now, as they busted up Schering-Plough, and dumped the pieces on Merck.
How many MORE times will public company CEOs be sold a sow's ear (at silk prices) by Hassan & Co.? That is what I wonder. . .
Watch out for (my speculation) a Bausch + Lomb public offering in 2011 or 2012. . . .
It is a sad prediction -- but likely to become fact. We shall see -- but my advice is not to buy in, should it be offered.
No comments:
Post a Comment